{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T08:40:08Z","timestamp":1750495208301,"version":"3.41.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,21]]},"DOI":"10.7759\/cureus.86473","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T08:13:02Z","timestamp":1750493582000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparative Efficacy and Safety of Direct Oral Anticoagulants Versus Warfarin in Valvular Atrial Fibrillation: A Systematic Qualitative Review"],"prefix":"10.7759","author":[{"given":"Moiuz","family":"Chaudhri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed D","family":"Al Mahrizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Faltas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Sakowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pranesh","family":"Rajendran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodie","family":"Borgmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vindhya","family":"Rapelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zehra","family":"Jaffri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quang","family":"La","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shrujal A","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick","family":"Acquah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Kaunzinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1137230","article-title":"Estimates of the global, regional, and national burden of atrial fibrillation in older adults from 1990 to 2019: Insights from the Global Burden of Disease study 2019","volume":"11","author":"Jiao M","year":"2023","unstructured":"Jiao M, Liu C, Liu Y, Wang Y, Gao Q, Ma A. Estimates of the global, regional, and national burden of atrial fibrillation in older adults from 1990 to 2019: Insights from the Global Burden of Disease study 2019. Front Public Health. 2023, 11:1137230. 10.3389\/fpubh.2023.1137230","journal-title":"Front Public Health"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.712585","article-title":"Comparison of the direct oral anticoagulants and warfarin in patients with atrial fibrillation and valvular heart disease: Updated systematic review and meta-analysis of randomized controlled trials","volume":"8","author":"Bitar YS","year":"2021","unstructured":"Bitar YS, Duraes AR, Roever L, Gomes Neto M, Lins-Kusterer L, Bocchi EA. Comparison of the direct oral anticoagulants and warfarin in patients with atrial fibrillation and valvular heart disease: Updated systematic review and meta-analysis of randomized controlled trials. Front Cardiovasc Med. 2021, 8:712585. 10.3389\/fcvm.2021.712585","journal-title":"Front Cardiovasc Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-016-1446-0","article-title":"Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation","volume":"43","author":"Zirlik A","year":"2017","unstructured":"Zirlik A, Bode C. Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation. J Thromb Thrombolysis. 2017, 43:365-79. 10.1007\/s11239-016-1446-0","journal-title":"J Thromb Thrombolysis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-14403-2","article-title":"Global, regional, and national burden of disease study of atrial fibrillation\/flutter, 1990-2019: Results from a global burden of disease study, 2019","volume":"22","author":"Li H","year":"2022","unstructured":"Li H, Song X, Liang Y, et al.. Global, regional, and national burden of disease study of atrial fibrillation\/flutter, 1990-2019: Results from a global burden of disease study, 2019. BMC Public Health. 2022, 22:2015. 10.1186\/s12889-022-14403-2","journal-title":"BMC Public Health"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000932","article-title":"2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive summary: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto CM","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO, et al.. 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive summary: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021, 143:e35-71. 10.1161\/CIR.0000000000000932","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S84210","article-title":"New oral anticoagulants: Their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events","volume":"11","author":"Mekaj YH","year":"2015","unstructured":"Mekaj YH, Mekaj AY, Duci SB, Miftari EI. New oral anticoagulants: Their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events. Ther Clin Risk Manag. 2015, 11:967-77. 10.2147\/TCRM.S84210","journal-title":"Ther Clin Risk Manag"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/cells11203214","article-title":"Anticoagulants: A short history, their mechanism of action, pharmacology, and indications","volume":"11","author":"Heestermans M","year":"2022","unstructured":"Heestermans M, Poenou G, Hamzeh-Cognasse H, Cognasse F, Bertoletti L. Anticoagulants: A short history, their mechanism of action, pharmacology, and indications. Cells. 2022, 11:3214. 10.3390\/cells11203214","journal-title":"Cells"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne JA","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, et al.. ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016, 355:i4919. 10.1136\/bmj.i4919","journal-title":"BMJ"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.026666","article-title":"Direct oral anticoagulants versus warfarin in patients with atrial fibrillation and valve replacement or repair","volume":"11","author":"Mentias A","year":"2022","unstructured":"Mentias A, Saad M, Michael M, et al.. Direct oral anticoagulants versus warfarin in patients with atrial fibrillation and valve replacement or repair. J Am Heart Assoc. 2022, 11:e026666. 10.1161\/JAHA.122.026666","journal-title":"J Am Heart Assoc"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7326\/M20-6194","article-title":"Effectiveness and safety of direct oral anticoagulants versus warfarin in patients with valvular atrial fibrillation : A population-based cohort study","volume":"174","author":"Dawwas GK","year":"2021","unstructured":"Dawwas GK, Dietrich E, Cuker A, Barnes GD, Leonard CE, Lewis JD. Effectiveness and safety of direct oral anticoagulants versus warfarin in patients with valvular atrial fibrillation : A population-based cohort study. Ann Intern Med. 2021, 174:910-9. 10.7326\/M20-6194","journal-title":"Ann Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.2099","article-title":"Clinical effectiveness of direct oral anticoagulants vs warfarin in older patients with atrial fibrillation and ischemic stroke: Findings from the patient-centered research into outcomes stroke patients prefer and effectiveness research (PROSPER) study","volume":"76","author":"Xian Y","year":"2019","unstructured":"Xian Y, Xu H, O'Brien EC, et al.. Clinical effectiveness of direct oral anticoagulants vs warfarin in older patients with atrial fibrillation and ischemic stroke: Findings from the patient-centered research into outcomes stroke patients prefer and effectiveness research (PROSPER) study. JAMA Neurol. 2019, 76:1192-202. 10.1001\/jamaneurol.2019.2099","journal-title":"JAMA Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.764356","article-title":"Direct acting oral anticoagulant vs. warfarin in the prevention of thromboembolism in patients with non-valvular atrial fibrillation with valvular heart disease-A systematic review and meta-analysis","volume":"8","author":"Martha JW","year":"2021","unstructured":"Martha JW, Pranata R, Raffaelo WM, Wibowo A, Akbar MR. Direct acting oral anticoagulant vs. warfarin in the prevention of thromboembolism in patients with non-valvular atrial fibrillation with valvular heart disease-A systematic review and meta-analysis. Front Cardiovasc Med. 2021, 8:764356. 10.3389\/fcvm.2021.764356","journal-title":"Front Cardiovasc Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2022.03.050","article-title":"Comparison of dabigatran versus warfarin treatment for prevention of new cerebral lesions in valvular atrial fibrillation","volume":"175","author":"Cho MS","year":"2022","unstructured":"Cho MS, Kim M, Lee SA, et al.. Comparison of dabigatran versus warfarin treatment for prevention of new cerebral lesions in valvular atrial fibrillation. Am J Cardiol. 2022, 175:58-64. 10.1016\/j.amjcard.2022.03.050","journal-title":"Am J Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom JW","year":"2013","unstructured":"Eikelboom JW, Connolly SJ, Brueckmann M, et al.. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med. 2013, 369:1206-14. 10.1056\/NEJMoa1300615","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano RP","year":"2013","unstructured":"Giugliano RP, Ruff CT, Braunwald E, et al.. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013, 369:2093-104. 10.1056\/NEJMoa1310907","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/377362-comparative-efficacy-and-safety-of-direct-oral-anticoagulants-versus-warfarin-in-valvular-atrial-fibrillation-a-systematic-qualitative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T08:13:02Z","timestamp":1750493582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/377362-comparative-efficacy-and-safety-of-direct-oral-anticoagulants-versus-warfarin-in-valvular-atrial-fibrillation-a-systematic-qualitative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,21]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.86473","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,21]]}}}